RDW in Athletes: Red Cell Distribution Width As An Early Indicator of Iron Deficiency
Introduction: Why RDW in Athletes Is Often Overlooked
In my clinical practice, the evaluation of anemia often focuses primarily on the complete blood count (CBC) and ferritin levels. In some cases, I extend the workup to include additional iron parameters such as transferrin saturation and serum iron.
However, one parameter I find is often overlooked—particularly when considering RDW in athletes—is RDW, or red cell distribution width, even though it is already included in every standard complete blood count.
Research demonstrates that up to 60% of high-level female athletes experience iron deficiency [1], yet the condition frequently goes undetected at early stages because conventional interpretation waits for markers that reflect late-stage depletion rather than the cellular changes that begin earlier.
Understanding RDW in athletes requires only one principle: it measures variation, not average. When that variation begins to widen in an athlete who feels only mildly fatigued, something is already changing at the level of red cell production—and acting at that stage is far easier than acting after hemoglobin drops.
What RDW Actually Measures
RDW quantifies the degree of variation in the size of circulating red blood cells—a property technically called anisocytosis. In a healthy person, red blood cells are remarkably uniform in volume, like coins pressed from the same die. When RDW rises, it means the circulating population has become heterogeneous: some cells are smaller and some are larger than the norm, widening the statistical spread of sizes across the sample.
On most modern automated haematology analysers, RDW is expressed as a coefficient of variation (RDW-CV) in percent. Reference ranges vary by analyser and laboratory. Values at the lower end reflect a uniform, efficiently produced red cell population. When RDW exceeds the upper reference limit, it signals that erythropoiesis has been disrupted—cells are being produced in variable sizes—which happens when the bone marrow is iron-limited, vitamin-depleted, or working under inflammatory stress.
The critical distinction is what RDW does not measure: average cell size. That is MCV’s job. MCV reports the mean corpuscular volume—the average size across the entire red cell population. RDW and MCV are complementary but independent. Two athletes can have an identical MCV of 88 fL, yet one has an RDW of 12.8% (uniform, healthy production) while the other has 14.9%—a mixed population of small new cells and older normal cells, consistent with early iron depletion. MCV misses this; RDW detects it.
In clinical practice, RDW is often interpreted as an indirect reflection of erythropoiesis, as it captures changes in red blood cell production over time.
A patient may present with an abnormal MCV, which in isolation provides limited insight into how that change has developed. When interpreted alongside RDW, it offers important additional context—helping to differentiate between a more recent shift in erythropoiesis and a more stable, longstanding pattern.
RDW and MCV: How to Interpret RDW in Athletes
In my clinical work, patients occasionally ask about RDW when it appears abnormal on their blood test. Since I order complete blood counts frequently—often as part of routine laboratory testing—this is a question that comes up from time to time.
What I typically explain is that interpreting RDW in isolation is almost meaningless. When interpreting RDW in athletes, its clinical value emerges when it is read alongside MCV, hemoglobin, and iron studies. In practice, a few key patterns are particularly useful, especially in athletic populations:
High RDW + Low MCV — consistent with iron deficiency anemia. The bone marrow has been iron-limited long enough that it now predominantly produces small, hypochromic cells (low MCV). These mix with older, still-normal cells creating wide size variation (high RDW). Both indices are abnormal. This pattern reflects advanced depletion, not early detection—it is precisely what RDW monitoring is designed to prevent.
High RDW + Normal MCV — possible early iron depletion or inflammatory iron restriction. This is the most practically important pattern for athletes in active training. The bone marrow is beginning to produce iron-restricted cells, but insufficient numbers have accumulated yet to pull the mean cell size downward. MCV appears normal while RDW silently widens. Research on 1,648 students across the full iron deficiency spectrum demonstrates that RDW-CV rises through the prelatent and latent stages of iron deficiency while the mean cell volume has not yet fallen to the point of clinical microcytosis—which was evident only at the established anemia stage [2]. Exercise-induced inflammation provides a parallel mechanism: elevated IL-6 drives hepatic hepcidin production, which reduces iron availability for erythropoiesis [5]. By reducing the iron supply available to developing red blood cells, this pathway may, over time, contribute to the emergence of a mixed red cell population in some athletes—though this mechanistic extension has not been directly confirmed in the context of RDW in the source.
On the other hand, a normal RDW in the presence of an abnormal MCV may suggest a more longstanding process, where macrocytosis or microcytosis has been present long enough for the red cell population to become relatively uniform.
This can be seen, for example, in chronic microcytic anemia—such as long-standing iron deficiency—or in prolonged macrocytic states, including megaloblastic anemia (such as pernicious anemia) or macrocytosis related to chronic alcohol use.
That said, it is worth acknowledging that RDW is rarely central to the diagnostic process. In most cases, it serves more as a supporting parameter rather than a primary driver of clinical decision-making.
Why RDW Rises Before MCV in Iron Depletion
This sequence—RDW rising while MCV remains in the normal clinical range—is the central mechanism that makes RDW a useful early signal, and it follows directly from the biology of red cell production.
Iron deficiency develops in stages. In the earliest stages—prelatent and latent iron deficiency—ferritin levels fall and iron stores begin depleting, but there is not yet sufficient limitation to produce cells small enough to shift the population average into microcytic territory. What does happen is that the newest red cells emerging from the bone marrow receive marginally less iron, making them a fraction smaller than the older, normally-formed cells still circulating. The overall mean (MCV) changes only modestly. The variation (RDW), however, starts widening immediately as this mixed population accumulates.
This staging has been directly documented. In a study of 1,648 students classified by iron status, RDW-CV values were 12.7±0.7% in normal individuals, rising to 13.2±0.8% in prelatent deficiency, 14.0±1.5% in latent deficiency, and 15.6±1.7% in established iron deficiency anemia. The authors reported that microcytosis was evident only in the iron deficiency anemia stage, while RDW-CV showed progressively larger values concomitant with the development of iron deficiency from the earliest stages [2].
In clinical practice, RDW can act as an early indicator of iron deficiency, sometimes before microcytosis becomes apparent. In this sense, it may provide an earlier signal of developing iron-restricted erythropoiesis than MCV, which often remains within the normal range in the initial stages.
An additional practical advantage is that RDW is already included in the standard complete blood count. This means it can offer useful supplementary information without requiring additional tests such as ferritin or other iron parameters—though it should always be interpreted in the appropriate clinical context.
RDW and Exercise: What Training Does to Your Red Cell Population
In athletes, understanding how training affects RDW in athletes requires understanding what exercise does to the red blood cell population itself.
Endurance training accelerates red cell turnover through mechanical hemolysis. In runners, foot-strike impact preferentially destroys older, more fragile senescent red blood cells, resulting in a circulating RBC population that skews younger in trained athletes compared to sedentary individuals [3]. This increased turnover creates a transiently more heterogeneous red cell population—a mixture of newly produced reticulocytes and older circulating cells—that can produce a short-lived, exercise-related RDW elevation distinct from nutritional deficiency.
Acute exercise data confirms this effect directly. In a prospective study of 31 middle-trained athletes completing a 21.1 km half-marathon run, RDW reached its peak 20 hours after the end of the run, with a median increase of 2.2% (IQR 0.8–3.3%) [4]. The odds ratio for an elevated RDW value (>13.8%) was 3.7 (95% CI, 1.03–13.4; P=0.044) at 20 hours post-race compared to baseline [4].
The practical consequence: blood drawn within approximately 20 hours of a hard training session or race is likely to reflect a transient hemolysis-related RDW elevation rather than true iron status. This is one of the most important practical considerations when interpreting RDW in athletes. For monitoring purposes, scheduling blood tests consistently—during a lower-intensity training period, with timing standardised across repeated assessments—allows meaningful trend comparison rather than point-in-time snapshot interpretation.
In athletes, RDW may be transiently elevated if the blood sample is taken relatively soon after exercise. This reflects the combined effects of exercise-induced hemolysis and compensatory reticulocytosis, which temporarily increase variability in red cell size.
However, this effect is typically modest and short-lived, and it should not be overinterpreted in isolation. In most cases, it does not warrant clinical conclusions on its own.
More broadly, RDW should not be used as a standalone marker. It is better understood as a supporting nuance—one that may add context to clinical decision-making when interpreted alongside other parameters, but rarely drives decisions independently.
Conclusion
RDW in athletes is not a headline marker in clinical practice, nor is it intended to be used in isolation. Yet, when interpreted in context, it provides a subtle but meaningful layer of insight into red blood cell dynamics.
In athletes—where iron deficiency is common and early changes in erythropoiesis may precede overt anemia—this additional nuance can be particularly valuable. RDW may reflect emerging shifts in red cell production before traditional markers such as MCV or hemoglobin become clearly abnormal, offering a small but potentially useful window for earlier recognition.
At the same time, its limitations are important to acknowledge. RDW is sensitive but non-specific, influenced by factors such as exercise-induced hemolysis and inflammation, and rarely sufficient to guide clinical decisions on its own. Its true value lies in pattern recognition—when combined with MCV, ferritin, and other iron parameters.
In the end, RDW is best understood not as a diagnostic endpoint, but as a supporting signal. It does not provide answers by itself, but when read carefully, it can help ask the right questions—often earlier than we otherwise might.
Bibliography
[1] https://pubmed.ncbi.nlm.nih.gov/39536912/
[2] https://pubmed.ncbi.nlm.nih.gov/2766669/
[3] https://pubmed.ncbi.nlm.nih.gov/24273518/
